- Home
- ALVO vs BHVN Comparison
ALVO vs BHVN Comparison
Compare ALVO & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALVO | BHVN |
|---|---|---|
| Founded | 2013 | 2013 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | ALVO | BHVN |
|---|---|---|
| Price | $4.13 | $11.22 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 14 |
| Target Price | $9.25 | ★ $27.69 |
| AVG Volume (30 Days) | 441.2K | ★ 2.0M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $20.85 | N/A |
| Revenue Next Year | $44.49 | N/A |
| P/E Ratio | $18.20 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.07 | $7.48 |
| 52 Week High | $12.25 | $38.23 |
Technical Indicators
Market Signals| Indicator | ALVO | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 25.25 | 45.37 |
| Support Level | $4.07 | $10.89 |
| Resistance Level | $5.31 | $11.84 |
| Average True Range (ATR) | 0.27 | 0.72 |
| MACD | -0.11 | -0.10 |
| Stochastic Oscillator | 2.89 | 24.09 |
Price Performance
Historical ComparisonAbout ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.